A white paper published by the Heart Rhythm Society (HRS) and National Stroke Association characterizes the impact of stroke on patients with atrial fibrillation (AF) and presents common barriers to effective communication among patients, caregivers, and physicians. The white paper, Impact of Stroke in Atrial Fibrillation, is a collaborative effort between the two organizations to improve education and diminish stroke risk in patients with AF.
ScImage announced that it has received validation for its PICOM365 enterprise picture archiving and communication system (PACS) within the framework of the Veterans Health Administration (VHA) system. The solution was validated as “Supported for HL7 Communication” with VHA’s VistA Imaging system.
A new independent evaluation report from the Department of Health and Human Services showed that the Pioneer Accountable Care Organization (ACO) payment model has generated substantial savings to Medicare in just two years. Additionally, the independent Office of the Actuary in the Centers for Medicare & Medicaid Services (CMS) has certified that this patient care model is the first to meet the stringent criteria for expansion to a larger population of Medicare beneficiaries.
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Pressure to create alternative payment models has led to a significant increase in provider interest in partnering with Premier Inc. to develop and implement population health management strategies.
Most community hospitals with cardiac catheterization labs share these facilities with multiple, non-interventional cardiology users, which can be challenging to manage various specialties’ needs. Beyond percutaneous coronary interventions (PCI), these labs are frequently shared with electrophysiologists (EP), vascular surgeons conducting endovascular repairs and interventional radiologists (IR) performing an array of non-coronary vascular or peripheral interventions.
Fujifilm Medical Systems U.S.A. said it completed its acquisition of TeraMedica Inc., a global healthcare informatics company and a provider of vendor neutral, enterprise solutions. The acquisition will allow Fujifilm to offer the market a leading vendor neutral archiving (VNA) technology.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
At Nebraska Medicine, technology innovations bring with them opportunities to enhance patient care. The ability to integrate patient images with synchronized and simultaneous audio and video has Nebraska Medicine’s telehealth coordinator Kyle Hall looking at new ways to implement telehealth and mobile devices, such as iPads and Google Glass, at clinics and hospitals.
Abbott and GE Healthcare announced an agreement that will bring real-time, patient-specific data about the heart's electrical activity to cardiac electrophysiology labs. The goal of the collaboration is to speed up the diagnosis of the sources of atrial fibrillation and other heart rhythm disorders.
For the first time, cardiac catheterization laboratory stakeholders now have quality metrics that confirm the value of Accreditation for Cardiovascular Excellence (ACE) accreditation. Three new studies validating the benefits of ACE accreditation were presented during the 2015 Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions in San Diego, California, May 6-9.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
A team from Stanford University School of Medicine has developed and combined new paper and flexible polymer substrates with special sensing devices for rapid and accurate detection of pathogens such as HIV and other biotargets. These novel technologies offer the type of robust, simple, and inexpensive biosensing systems required to provide point-of-care healthcare in remote areas, where there is minimal diagnostic infrastructure or equipment and a lack of trained medical technicians.
Cardiovascular Systems Inc. (CSI) featured two-year data from its ORBIT II study of the company’s Diamondback 360 coronary orbital atherectomy system (OAS) in a late-breaking presentation at the 2015 Society for Cardiovascular Angiography and Interventions (SCAI) conference. Diamondback 360 is a U.S. Food and Drug Administration (FDA)-approved atherectomy technology indicated for the treatment of severely calcified lesions.
CardiAQ Valve Technologies announced U.S. Food and Drug Administration (FDA) Investigational Device Exemption (IDE) approval for a feasibility study of its second generation transfemoral (TF) and transapical (TA) transcatheter mitral valve implantation systems. The study will enroll up to 20 patients (10 TF and 10 TA) and multidisciplinary physician teams at select U.S. sites will start enrollment once hospital approvals and agreements are in place.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Spok Inc. announced the availability of message notifications on the Apple Watch wrist wearable device to enable clinicians to enhance care coordination. The Spok Mobile secure texting app is currently used by numerous hospitals to give users quick access to the organization’s directory, allowing staff to communicate securely through encrypted text, image and video messages. In addition, the app can receive alerts from patient care, nurse call and other monitoring systems to speed response to critical situations.
While demand for electrocardiogram (ECG) monitoring systems is increasing, a major hurdle has been the necessity of gel electrodes for reliable long-term measurements. The electrodes dry out within 24 hours, after which they no longer produce useable signals. They are also not very suitable for older patients who frequently sweat less and are less mobile than younger subjects. A team of Swiss researchers, however, recently unveiled a new chest strap heart rate monitor featuring wettable electrodes.
May 11, 2015 — The Heart Rhythm Society (HRS) has released the list of its 12 late-breaking electrophysiology (EP) clinical trials that will be presented at Heart Rhythm 2015, which takes place May 13-16, 2015 in Boston.